Mechanism of Active Steroid Alkaloids from <italic style="font-style: italic">Solanum nigrum</italic> Against Non-small Cell Lung Cancer： Based on Network Pharmacology

Liang-yu LIU; Yu-ke YANG; Jian-nong WANG

doi:10.13422/j.cnki.syfjx.20211418

您当前的位置：

首页 >

文章列表页 >

Mechanism of Active Steroid Alkaloids from Solanum nigrum Against Non-small Cell Lung Cancer： Based on Network Pharmacology

更新时间：2021-11-12

- Mechanism of Active Steroid Alkaloids from Solanum nigrum Against Non-small Cell Lung Cancer： Based on Network Pharmacology
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 24, Pages: 178-185(2021)
- 作者机构：
  
  中国中医科学院西苑医院基础医学研究所，中药药理北京市重点实验室，北京 100091
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20211418
  CLC： R285;R289;R22;R2-031;R33
- Published：20 December 2021，
  
  Published Online：14 October 2021，
  
  Received：09 August 2021，
- 稿件说明：
扫描看全文
刘良裕,杨宇珂,王建农.龙葵甾体生物碱抗非小细胞肺癌网络药理学分析[J].中国实验方剂学杂志,2021,27(24):178-185.

LIU Liang-yu,YANG Yu-ke,WANG Jian-nong.Mechanism of Active Steroid Alkaloids from Solanum nigrum Against Non-small Cell Lung Cancer： Based on Network Pharmacology[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):178-185.
刘良裕,杨宇珂,王建农.龙葵甾体生物碱抗非小细胞肺癌网络药理学分析[J].中国实验方剂学杂志,2021,27(24):178-185. DOI： 10.13422/j.cnki.syfjx.20211418.

LIU Liang-yu,YANG Yu-ke,WANG Jian-nong.Mechanism of Active Steroid Alkaloids from Solanum nigrum Against Non-small Cell Lung Cancer： Based on Network Pharmacology[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):178-185. DOI： 10.13422/j.cnki.syfjx.20211418.

摘要

目的

研究龙葵甾体生物碱抗非小细胞肺癌（NSCLC）的潜在作用靶点和通路，分析其抗NSCLC的可能作用机制。

方法

查阅文献筛选出龙葵中具有抗NSCLC活性的甾体生物碱（SASN），通过SwissTargetPrediction，PharmMapper及GeneCards数据库分别获得SASN和NSCLC的全部靶点，利用Venny在线软件获取二者共同靶点，并运用Cytoscape软件构建“药物-成分-靶点-疾病”作用网络图，利用Metascape对共同靶点进行富集分析，进一步预测潜在通路。借助STRING数据库得到蛋白质-蛋白质相互作用网络（PPI），通过网络拓扑数据分析筛选出关键靶点，并通过蛋白免疫印迹法（Western blot）验证药物对关键靶点的影响。

结果

经过筛选得到6个SASN，包括澳洲茄碱、澳洲茄边碱、澳洲茄胺、毛叶冬珊瑚碱、龙葵次碱和氮甲基澳洲茄碱，对SASN和NSCLC全部靶点取交集后得到SASN抗NSCLC的潜在作用靶点共有96个，京都基因与基因组百科全书（KEGG）富集分析表明潜在靶点涉及的通路主要包括癌症通路、癌症蛋白聚糖通路和Forkhead box protein O （FoxO）通路等。PPI网络分析显示，蛋白激酶B1（Akt1），丝裂原活化蛋白激酶1（MAPK1），MAPK8，MAPK14，信号传导及转录激活蛋白3（STAT3）及原癌基因酪氨酸蛋白激酶（SRC）等15个靶点可能是SASN抗NSCLC的关键作用靶点；同时，Western blot结果显示龙葵生物碱可以显著下调Akt1，STAT3和SRC 3个关键蛋白的表达。

结论

该研究预测了SASN抗NSCLC的潜在作用靶点和信号通路，获得了SASN抗NSCLC的关键作用靶点，并从15个关键靶点中选取3个关键蛋白进行了验证，验证结果与靶点预测相一致，为后续深入研究龙葵甾体生物碱抗NSCLC作用机制提供了科学的指导。

Abstract

Objective

To explore the potential targets and pathways of steroid alkaloids

from

Solanum

nigrum

（SASN） in the treatment of non-small cell lung cancer （NSCLC） and analyze the possible mechanism.

Method

The active SASN against NSCLC were searched from literature. Then potential targets of SASN were screened through SwissTargetPrediction and PharmMapper， and those of NSCLC through GeneCards. Venny was employed to yield the common targets of the two， and Cytoscape to construct the 'medicinal-component-disease-target' network. Metascape was applied to enrich the Gene Ontology （GO） terms and Kyoto Encyclopedia of Genes and Genomes （KEGG） pathways of the common targets， and STRING was used to generate the protein-protein interaction （PPI） network， followed by screening of key targets by Cytoscape. Finally， Western blot was used to verify the effects of the medicinal on key targets.

Result

A total of 6 active SASN were screened out： solasonine， solamargine， solasodine， solanocapsine， solanidine， and

-methylsolasodine， which had 96 potential anti-NSCLC targets. These targets mainly involved the pathways in cancer， proteoglycans in cancer， and Forkhead box protein O （FoxO） pathway. PPI network analysis demonstrated 15 key anti-NSCLC targets of SASN， such as mitogen-activated protein kinase （MAPK）1， MAPK8， MAPK14， protein kinase B （Akt1）， signal transducer and activator of transcription 3 （STAT3）， and proto-oncogene tyrosine protein kinase （SRC）. Meanwhile， Western blot results showed that SASN could significantly down-regulate the expression of the key proteins Akt1， SRC， and STAT3.

Conclusion

We predicted the potential targets and pathways of SASN against NSCLC and obtained 15 key targets， from which we selected three key proteins for validation. The validation results were consistent with the prediction results. This paper is expected to lay a scientific basis for the subsequent in-depth study of the mechanisms of SASN against NSCLC.

关键词

龙葵甾体生物碱非小细胞肺癌作用机制网络药理学

Keywords

Solanumnigrumsteroid alkaloidnon-small cell lung cancermechanismnetwork pharmacology

references

ORGANIZATION W H.Latest global cancer data： cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020［EB/OL］.（2021-01-06）［2021-08-09］.https：//www.iarc.fr/faq/latest-global-cancer-data-2020-qa/https://www.iarc.fr/faq/latest-global-cancer-data-2020-qa/.

WINSTON W，TAN M D.Non-small cell lung cancer （NSCLC）［EB/OL］.（2021-07-15）［2021-08-09］.https：//emedicine.medscape.com/article/279960-overviewhttps://emedicine.medscape.com/article/279960-overview.

AMERICAN CANCER SOCIETY.Cancer facts & figures 2015.Atlanta： American cancer society，2015［EB/OL］.（2015-12-26）［2021-08-09］.http：//www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdfhttp://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf.

李红念，蒋启明，梅全喜，等.龙葵的化学成分与药理作用研究进展［J］.今日药学，2011，21（11）：713-715.

梅全喜，张志群，林慧，等.龙葵治疗肿瘤的药理作用与临床应用研究进展：中华名中医论坛暨发挥中西医优势防治肿瘤高峰论坛［C］//中华中医药学会，广东省中医药学会.全国毒性中药饮片学术研讨会论文集，2011卷.

广东中山，2011.

CHEN Y，TANG Q，XIAO Q，et al.Targeting EP4 downstream c-Jun through ERK 1/2-mediated reduction of DNMT 1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells［J］.J Cell Mol Med，2017，2（21）：222-233.

黄文斯，王颖，朱海涛，等.澳洲茄碱诱导肺癌细胞株H446凋亡及其机制探讨［J］.中国肺癌杂志，2015，（7）：416-421.

韩林.白英生物碱对非小细胞肺癌的抑制作用及凝集脂筏胆固醇抑制血管新生的抗肿瘤机制研究［D］.北京：中国中医科学院，2017.

周新兰.中药龙葵抗癌活性成分研究［D］.沈阳：沈阳药科大学，2006.

DAINA A，MICHIELIN O，ZOETE V.SwissTargetPrediction： updated data and new features for efficient prediction of protein targets of small molecules［J］.Nucleic Acids Res，2019，47（W1）：W357-W364.

XIA W，YIHANG S，SHIWEI W，et al.PharmMapper 2017 update： a web server for potential drug target identification with a comprehensive target pharmacophore database［J］.Nucleic Acids Res，2017，45（W1）：W356-W360.

STELZER G，ROSEN N，PLASCHKES I，et al.The GeneCards suite： from gene data mining to disease genome sequence analyses［M］.Chichester：John Wiley & Sons，Ltd，2016，doi：10.1002/cpbi.5http://dx.doi.org/10.1002/cpbi.5

ZHOU Y，ZHOU B， PACHE L，et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets［J］.Nat Commu，2019，10（1523）：325-347.

HNASKO T S，HNASKO R M.The Western blot［J］.Methods Mol Biol，2015，doi：10.1007/978-1-4939-2742-5_9http://dx.doi.org/10.1007/978-1-4939-2742-5_9

王永炎，曹洪欣.中国中医科学院中医优势病种研究［M］.北京：中国中医药出版社，2011：256.

张星星，李泽庚.肺癌中医病因病机探讨［J］.中华中医药杂志，2015，2（10）：3447-3449.

乔路敏，张培彤.清热解毒法治疗肺癌辨析［J］.中国肿瘤，2014，23（4）：316-321.

石芳，巫林，王妍，等.龙葵提取物澳洲茄碱对肺癌细胞侵袭及MMPs/TIMPs表达的影响［J］.肿瘤药学，2018，8（3）：337-341，346.

黄越燕，朱琦峰，周燕，等.龙葵生物碱体外抑制肿瘤细胞增殖作用的实验研究［J］.亚太传统医药，2012，8（9）：31-33.

陈来，李姗姗，金德忠，等.中药龙葵提取物澳洲茄碱对肺癌细胞抑制作用［J］.时珍国医国药，2015，5（2）：333-334.

耿其顺，朱子家，王文斌，等.基于网络药理学研究龙葵抗肺癌的生物作用机制［J］.中国临床药理学杂志，2020，313（11）：182-185.

刘燕玲，吴美玲，胡莹，等.基于加权基因共表达网络分析（WGCNA）探讨龙葵抗肺腺癌功能基因模及生物标记识别研究［J］.中草药，2019，50（24）：6073-6083.

KADOTA T，YOSHIOKA Y，YU F，et al.Extracellular vesicles in lung cancer-from bench to bedside［J］.Semin Cell Dev Biol，2017，67：39-47.

HOSHINO A，COSTA-SLIVA B，SHEN T L，et al.Tumour exosome integrins determine organotropic metastasis［J］.Nature，2015，527（7578）：329-335.

KUMAR R，CHAUDHARY K，GUPTA S，et al.Cancer DR：cancer drug resistance database［J］.Sci Rep，2013，3：1445.

王威.Src和GSTA1在肺腺癌转移中的作用及机制研究［D］.济南：山东大学，2018.

WANG W P，YING S，LU Q，et al.Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway［J］.Oncotarget，2016，8（4）：5909.

TANNO S，TESTA J R，KOHGO Y.AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells［J］.Cancer Res，2001，120（5-supp-S1）：A39-A40.

ADATIA R，ALBINI A，CARLONE S，et al.Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA［J］.Ann Oncol，1997，8（12）：1257-1261.

SHARMA B，HANDLER M，EICHSTETTER I，et al.Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo［J］.J Clin Invest，1998，102（8）：1599-1608.

COUCHMAN J R，CHEN L，WOODS A. Syndecans and cell adhesion［J］.Int Rev Cytol，2001，207： 113-150.

KATO M，SAUNDERS S，NGUYEN H，et al.Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells［J］.Mol Biol Cell，1995，6（5）：559.

MAEDA T，DESOUKY J，FRIEDL A.Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis［J］.Oncogene，2005，25：1408-1412.

BRUNET A，GREER E L.FOXO transcription factors at the interface between longevity and tumor suppression［J］.Oncogene，2005，24（50）：7410.

ZHANG Y，GAN B，LIU D，et al.FoxO family members in cancer［J］.Cancer Biolo Ther，2011，12（4）：253-259.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Study on Mechanism of Action of Matrine in Treatment of Inflammatory Bowel Disease Based on Zebrafish Model and Network Pharmacology

Mechanism of Chenpi Huoxiangtang Against Diarrhea： Based on Network Pharmacology and Experimental Verification

Mechanism of Xianglian Huazhuo Prescription Against Chronic Atrophic Gastritis Based on Network Pharmacology and Experimental Verification

Mechanism of Dendrobium huoshanense in Treatment of Gastric Ulcer： Based on Network Pharmacology and in Vivo Experiment

Mechanism of Wenshen Yangxue Prescription Improving Endometrial Receptivity of Aged Female Mice by Regulating PI3K/Akt/FoxO3A Signaling Pathway

Related Author

CHEN Linzhen

ZHANG Xue

CHEN Qi

YU Xue

DAI Shengyun

MA Zhiqiang

ZHAO Chongjun

LI Zhe

Related Institution

Beijing Key Laboratory of Traditional Chinese Medicine（TCM） Quality Evaluation， Beijing University of Chinese Medicine

School of TCM， Beijing University of Chinese Medicine

National Institutes for Food and Drug Control

Hebei Province Key Laboratory of Study and Exploitation of Chinese Medicine， Chengde Medical College

Hebei Key Laboratory of Nerve Injury and Repair， Chengde Medical University

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Mechanism of Active Steroid Alkaloids from Solanum nigrum Against Non-small Cell Lung Cancer： Based on Network Pharmacology

DOI：10.13422/j.cnki.syfjx.20211418

摘要

Abstract

关键词

Keywords

references